Bioadaptives (BDPT) EBIAT (2019 - 2025)
Historic EBIAT for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to -$379502.0.
- Bioadaptives' EBIAT fell 90800.02% to -$379502.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 3974.82%. This contributed to the annual value of -$904761.0 for FY2024, which is 2699.01% down from last year.
- According to the latest figures from Q3 2025, Bioadaptives' EBIAT is -$379502.0, which was down 90800.02% from -$157914.0 recorded in Q2 2025.
- In the past 5 years, Bioadaptives' EBIAT registered a high of -$13061.0 during Q3 2023, and its lowest value of -$491903.0 during Q1 2021.
- Over the past 5 years, Bioadaptives' median EBIAT value was -$223837.0 (recorded in 2022), while the average stood at -$226173.5.
- Per our database at Business Quant, Bioadaptives' EBIAT surged by 9527.33% in 2023 and then crashed by 90800.02% in 2025.
- Bioadaptives' EBIAT (Quarter) stood at -$214283.0 in 2021, then soared by 86.8% to -$28277.0 in 2022, then crashed by 848.83% to -$268301.0 in 2023, then tumbled by 40.66% to -$377388.0 in 2024, then fell by 0.56% to -$379502.0 in 2025.
- Its EBIAT was -$379502.0 in Q3 2025, compared to -$157914.0 in Q2 2025 and -$197136.0 in Q1 2025.